Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type (1 selected)

Type

Guidance programme

Showing 301 to 325 of 1904

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Upadacitinib for treating active non-radiographic axial spondyloarthritisTA861
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatmentsTA862
Somatrogon for treating growth disturbance in children and young people aged 3 years and overTA863
Nintedanib for treating idiopathic pulmonary fibrosis when forced vital capacity is above 80% predictedTA864
Maribavir for treating refractory cytomegalovirus infection after transplantTA860
Delirium: prevention, diagnosis and management in hospital and long-term careCG103
Trabeculectomy with a biodegradable collagen matrix implant for glaucomaIPG750
Angiotensin II for treating vasosuppressor-resistant hypotension caused by septic or distributive shock (terminated appraisal)TA859
Tobacco: preventing uptake, promoting quitting and treating dependenceNG209
Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and educationNG213
MRI-based technologies for assessing non-alcoholic fatty liver diseaseDG50
Nivolumab with platinum- and fluoropyrimidine-based chemotherapy for untreated HER2-negative advanced gastric, gastro-oesophageal junction or oesophageal adenocarcinomaTA857
Lenvatinib with pembrolizumab for untreated advanced renal cell carcinomaTA858
Laparoscopic insertion of a magnetic ring for gastro-oesophageal reflux diseaseIPG749
Transcutaneous electrical stimulation of the trigeminal nerve for ADHDIPG748
Hip fracture: managementCG124
Upadacitinib for treating moderately to severely active ulcerative colitisTA856
Percutaneous image-guided cryoablation of peripheral neuroma for chronic painIPG747
Thyroid cancer: assessment and managementNG230
Avatrombopag for treating primary chronic immune thrombocytopeniaTA853
Cabozantinib for previously treated advanced hepatocellular carcinomaTA849
Amivantamab for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapyTA850
Pembrolizumab for neoadjuvant and adjuvant treatment of triple-negative early or locally advanced breast cancerTA851
Trifluridine–tipiracil for treating metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma after 2 or more treatmentsTA852
Esketamine nasal spray for treatment-resistant depressionTA854

Results per page

  1. 10
  2. 25
  3. 50
  4. All